NCT07326553 is a Phase 4 clinical trial of Placental Membrane in Diabete Mellitus, sponsored by BioXTek.

Who is sponsoring NCT07326553?

NCT07326553 is sponsored by BioXTek.

What drugs are being tested in NCT07326553?

Interventions in NCT07326553: Placental Membrane.

What condition does NCT07326553 study?

NCT07326553 studies Diabete Mellitus, Foot Ulcer Chronic.

Is NCT07326553 still recruiting?

NCT07326553 is currently recruiting now. Last updated 8 January 2026.

Last reviewed 2026-01-08 · How we verify

NCT07326553

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing

Recruiting now Phase 4 Last updated 8 January 2026

What this trial tests

Phase 4 trial testing Placental Membrane in Diabete Mellitus in 30 participants. Currently enrolling.

Timeline

1 December 2025

Primary endpoint
31 July 2026

31 December 2026

Quick facts

Lead sponsor	BioXTek
Phase	Phase 4
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	30
Start date	1 December 2025
Primary completion	31 July 2026
Estimated completion	31 December 2026
Sites	2 locations across United States

Drugs / interventions tested

Placental Membrane — full drug profile →

Conditions studied

Diabete Mellitus — all drugs for Diabete Mellitus →
Foot Ulcer Chronic — all drugs for Foot Ulcer Chronic →

Sponsor

BioXTek — full company profile →

Who can join

Adults 45 to 85, any sex, with Diabete Mellitus or Foot Ulcer Chronic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of Efficacy of Placental Membrane Dressings in Accelerating Diabetic Foot Healing

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Diabete Mellitus

Currently open trials in the same condition.

NCT07378956 — Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus · NA · recruiting
NCT07432893 — Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts · NA · recruiting
NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
NCT07293156 — Impact of Pilates Exercises on Diabetic Erectile Dysfunction. · NA · recruiting
NCT07496593 — Total Intravenous and Balanced Anesthesia in Diabetic Patients Undergoing Video-Assisted Thoracoscopy · Phase 4 · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07326553 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by BioXTek
Last refreshed: 8 January 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07326553.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing